Publication | Closed Access

A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.

Metastatic Breast CancerBreast OncologyMedicineCancer ManagementPharmacologyClinical TrialsWeekly PaclitaxelBreast CancerPharmacotherapyCancer TreatmentOncologyFinal Analysis